The DINO Trial

Phase 3

Completed

• Conditions: Preterm Infants < or = 32 weeks; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12606000327583
• Lead Sponsor: ational Health and Medical Research Council

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2003-03-27
• Study Completion: 2013-07-10
• Last Update Posted: 22 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 657

Inclusion Criteria

1. Infants born < or = 32 weeks gestation 2. Signed written informed consent 3. Family/guardians who speak English

Exclusion Criteria

1. Infants with major congenital or chromosomal abnormalities 2. More than 5 days after commencing enteral feeds 3. Lactating mother with blood clotting disorder where tuna oil is contraindicated or regularly taking anticoagulant therapy 4. Participation in other clinical trials involving fatty acid intervention 5. Geographic location 6. Multiple births where not all live born infants are eligible.

Study & Design

• Study Type: Interventional
• Study Design: Not specified